{"Name":"Amphivena Therapeutics","perma":"amphivena-therapeutics","BasicInfo":{"funded":"2012-01-01","isClosed":false,"closed":null,"short":"Amphivena Therapeutics, a subsidiary of Affimed Therapeutics, develops treatments to address hematologic malignancies."},"FundingRounds":[{"funding_type":"venture","series":"A","announcedDate":"2015-05-04","moneyRaised":14000000},{"funding_type":"venture","series":"a","announcedDate":"2013-07-15","moneyRaised":14000000}],"Acquisitions":[],"AcquiredBy":null,"IPO":null,"Investments":[],"Products":[],"CurrentTeam":[{"title":"President and CEO","started":null,"ended":null,"firstName":null,"lastName":null}],"PastTeam":[]}
